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Mwengcr RNA I’rom intact rat pancreatic islets. or kom mmsformcd hiunstcr beta (HIT) cells. hybridized with the cDNA probe for ~ypc I (but 
not type II) phospholipasc A:. The levels ofphospholipese Al mRNA incrcascd in islets from fnstcd rats: they dccrcascd in isictsculturcd in ;I high 
glucose conccnlrinion (control values itl 5.5 nib1 glucose = 150+6% 0r those at 22 mM) which impaired subrcqucnt insulin secretion (reduction 
in second-phase rclcasc = 70+ I I%). Thcsc studies uniquely dcnl0nstratc ~hnt type I phospholipasc A2 is cxprcsscd spccificnlly in bctn cells and 
that nutrient availability modulates transcript Icvcls. an cfkt which could contribute to the dctrimcnt;ll inllucncc of prolonged hypcrglyccmia on 
islet runction. 
Insulin; Pancreatic islet: Phospholipasc: Glucose; Beta cell: Fasting 
I. INTRODUCTION 
Rat pancreatic islets contain one (or more) phospho- 
lipnscs of the A, type (PLA,); furthermore, considerable 
data implicate PLA, in the reglulation of insulin secre- 
tion through the mediation of the phospholipid hydro- 
lysis products generated (i.e. arachidonic acid and ly- 
sophospholipids) (summarized in [I]). However, little is 
known about the type of PLA, present in endocrine 
cells. Phospholipnses A, can be sudivided into two gen- 
eral groups [2] based on structural determinants. Type 
I PLA, is found in mammals. in the exocrine pancreas. 
lung, gastric mucosa. and spleen. The regulation of type 
1 PLA? gene expression is unexplored. Type 11 PLA?. in 
contrast. is present in platelets, inflammatory exudates, 
vascular smooth muscle, chondrocytes. synovial cells. 
spleen, platelets, mesanginl cells and placcnt;~. Using 
cDNA probes directed against type 1 or type II PLA,. 
we examined pancreatic islets, transformecl pancreatic 
beta cells, aird other endocrine glands, to assess the 
regulation of PLA? mRNA levels in two states in which 
altered nutrient availability is known to perturb insulin 
release - fasting, and exposure to high glucose concen- 
trations. The former inhibits PLA, activity [3] and im- 
pairs physiologic insulin release [4]. ‘Glucotoxic’ islets 
also have impaired insulin secretion [5]. Thcsc studies 
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comprise the first data addressing the presence of the 
gene for phospholipase A,: and the regulation of its 
expression. in a peptide-secreting endocrine gland. 
2. MATERIALS AND METHODS 
The CDNA probes ror PLA? iypcs I und II (cloned I’rom cDNA 
librnrics isolntcd rrom rat pancreas and spleen. rcspcctivcly) wcrc 
gcncrously provided by Shionogi Rcscarch Laboratories (Osukn. 
J;tpiln) end arc dcscribcd in dcIi\i; in their publications [6-S]. Thr: 
probe I’or mouseP-actin was provided by Dr. l3rucc Spicgclmnn (Bos- 
ton. MA). Dcoxycytidinc-Y-triphosphatc (dCTP). tctratri~thyliltntno- 
nium salt. [GP]-. having a spccilic activity 0r 3000 Ci/mniol. wiis 
purchased rrom ICN Biomcdials. Inc. (Cos~a Mesa. CA). 
Islets. isohltcd iron1 malt Sprilguc-D;t\vlcy rats. as dcscribcd [9]. 
wcrc scqucntinlly handpicked on I\VO scpnrittf occilsions under stcrco- 
microscopic control in order to rigidly exclude cont;mlinatioa by CYO- 
crinc pnncrcntic cells [3]. For studies of the csposurc to dilkrcnt 
glucose conccntriitions or lo various test conipounds. isicts wrc cui- 
turcd Ibr 18-20 h in CMRL IOGG medium containing 5% ktal calf 
swum. 100 U/ml penicillin. IOO~~ml streptomycin. and the indicated 
test agents. and wcrc suspended in I ml 01’4 M guanidinium thiocy;t- 
nutc and kept iII -70JC until rurilicr processing. RNA ws obtained 
by ccnlrifuginion through ccsiunl chloride [IO]. For studies 01’ whole 
pancrcns. RNA was extracted ant1 rcsuspcndcd in the prcscncc 01‘0.2% 
dicthylpyrocnrbonats 10 inhibit RNascs active in what tissue [I I]. A 
similar protocol wits used to stcdy dynamic illsulin sccrction from 
thcsc islcls cxccpl thnt IO% ktal ciilrscruni was present overnight; 100 
islets wcrc plnccd into each chamber and pcrifuscd, using a previously 
described procedure [I& in Krcbs-Ringer bicitrbonatc bulk, Tar 5 
min at 4.4 mM glucose, followed by 76 min nt 27.5 mM glucose. 
ElIlucnt mcdiunt wts collcctcd cvcry I min Ibr I5 min and then cvcry 
2 min. Tntnsformcd Syrian hiwtcr bcto ccll~ w’crc m;tint;lincd in 
culture in RPM1 1640 tncdium ils previously described in detail [I 31. 
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Approximately equal amounls or dcnaturcd total cellular RNA 
(5--l 5 11 per lane) was clcctrophorcscd on 0.8% agarosc and 2.7% 
forma;izhydc gels. biotizz onlo nitroccllulosc membranes, and cross- 
iinkcd by baking at 80°C for 2 h in a vacuum oven. DNA probes for 
PLA: :ypc I alld II, and Tar /I-actin. wcrc labeled with [‘:P]dCTP by 
1hc random-primer method or nick translation using Bochringcr- 
Mannhcim labcling ki1s. Prchybridization (and hybridization) was 
carried out in 0.007 M Tris-HCI. pH 8.0. containing IO% dcxlran 
sulfate, 40% dcionizcd rormamidc, 4 x SK. 0.8 x Dcnhardt’s solulion. 
and ?O &ml dcnaturcd salmon-sperm DNA, Tar I6 h at 4FC; “P- 
lab&d cDNA was added during hybrldizdtion. The hybridized blots 
were washed 4 times in 2 x SSC and 0.1% SDS ror 5 min at room 
tcmpxalurc and subscqucntly twice in 0.5 x SSC and 0.1% SDS Tar 
30 min at 55OC. Autoradiographic cxposurcs of the blots to Kodak 
X-Omat AR film wcrc carried out at -70°C using two intensifying 
screens. The lcvcls or RNA transcripts wcrc mcasurcd by vertically 
scanning autoradiograms with a video dcnsitomcter (Bio-Red, model 
620). Gcnc trenscript concentrations arc cxprcsscd as the dcnsitome- 
tric ratio Tar each band oTPLA, gcnc transcript compdrcd IO the value 
for the corresponding j&actin peak. HIT cell RNA WIS analyzed on 
I .5% agerose-formaldehyde gels and transrcrrcd to a nylon hybridiza- 
tion ntcmbrancs (Micron Separations, WcstTord, MA) by clcctroblot- 
tin&. 
3. RESULTS 
A strong signal for type I PLAz (transcript size: 0.95 
kb) was consistently found using freshly isolated or 
overnight-cultured rat islets (Fig. I); no signal for type 
II PLA, was detected. A similar signal was detected in 
studies using HIT cells (Fig. I), No signal for either type 
of PLA, was detected in adrenal glands, testes, or un- 
fractionated pituitary glands (40 ,ug of RNA from 1-3 
pituitaries was applied to each lane). In rats fasted for 
48 h, islet levels of PLAl (type I) mRNA increased from 
control values of 0.59kO.16 to I .49+0.32 (/1=5 experi- 
ments, mean + SE; PcO.05). Refeeding was associated 
with values which had returned towards control 
(0.96-1-0.19; rr=3). As expected [2], unfraction- 
ated pancreas (which is overwhelmingly comprised of 
exocrine tissue) also expressed type I PLA!. However, 
in sharp contrast to the findings with islets, fasting ac- 
tually rehrcctl PLA, signal to 631-5% of levels in pan- 
creases from fed rats (control = 3.4911.02; fasted = 
2.43 i: 0.82; t1=7 experiments; P=O.Ol). 
Compared to islets cultured for 18-20 h at 5.5 mivl 
glucose, islets cultured at 22 mM glucose had reduced 
PLA? mRNA levels in each of 6 separate paired experi- 
ments (high glucose culture: 2.00i0.88; normal glucose 
culture: 3.04+0.65; PcO.05). Such treatment did not 
alter first phase (O-7 min) insulin release; however, in 
each of 5 paired studies, second phase secretion (8-60 
min), expressed as the incremental areas above basal 
levels, was reduced by 70+ 11% (Fig. 2) from 
15 772 f 4411 to 4535 I!I 1535 ,uU WO.05). 
In certain non-endocrine cells which synthesize a se- 
crctory, type I1 PLA?, gene expression is augmented by 
cyclic AMP or interleukins [14,15]. However, culture of 
islets with 200 PM dibutyryl cyclic AMP (control 
a. Normal Hat Islets 
A 
c. Normal 1s1elo: Effect of Slarvation 
A B C 0 E F G H 
.-; .:. 
Fig. I, Dctcction or type I phosphohpasc AI mRNA in insulin-sccrct- 
ing tissues. (a) Normal rat islets (lane A contains RNA from 1800 
islets. lane B rrom 2800 islets). (b) HIT cetls rrom passages 71.80. 87 
and 98. (c) Norinal rat islets idicr 48 h fasting (lanes A--D) vs. islets 
From Ted rats (lanes E-H). 
1.38kO.13; CAMP: I .60 k0.22; 11=4 pairs; 
P=NS) or 5 ,uM forskolin (control: 1.64+_0.03; forsko- 
lin: 1.34+0.07; r1=3) did not significantly alter PLA? 
mRNA. 
oL?--L’ 1 0 9 ’ ’ ’ ’ ’ J 
-2024 8 12 162024233236404448525560 
Minutes 
Fig. 2. Mean insulin Jevcls upon raising glucose concentration from 
4.4 mM to 27.5 mM (arrow) in islets cultured at 5.5 mM ~IUCOSC (a) 
or at 22 mM (/I). Basal insulin lcvcls avcrayd SG+ :5 and 52+G 
~Ulml. rcspcctivcly. and wcrc noI significunlly dilTcrcnt bctwccn the 
two conditions. 
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4. DlSCUSSlON 
These data establish, for the first time, type 1 PLA? 
gene expression in an endocrine gland (islets of Langer- 
bans). Although type I PLA, is expressed in pancreatic 
exocrine tissue ([2] and current studies), contamination 
with such cells does not explain the findings with islets 
since the latter were twice hand-picked to exclude all 
acinar tissue. Furthermore. the PL& mRNA levels 
were regulated in a diametrically-opposed fashion in the 
two tissues, with fasting increasing them in the endo- 
crine pancreas and decreasing them in the exocrine pan- 
creas. Additionally. the presence of the message in HIT 
cells demonstrates that beta cells in particular express 
PLA,; indeed, PLA? activity is demonstrable not only 
in intact adult rat islets [I61 but in cultured monolayers 
of neonatal rat islet cells [ 17. IS] which are comprised 
(90-980/o) of beta cells. No signal for type 11 PLA,, was 
seen: this indicates the specificity of our findings, since 
types I and II PLA, share a degree of sequence homo- 
logy [l9]. 
Forty-eight hours of fasting markedly increased 
PLA? message. Since PLA, activity is reportedly de- 
creased by starvation [3]. we speculate that the former 
observation reflects a compensatory effect on transcrip- 
tion (or mRNA stability) in response to an impairment 
of PLA, activity by fasting. For example, fasting re- 
duces Ca” influx into islets [20]; cytosolic Ca’+ levels 
are a major determinant of PLA, activity [l6]. 
An area of much current interest is the ability of 
subacute or chronic elevations in ambient glucose levels 
to impair signal transduction in the beta cell, i.e. ‘glu- 
cose toxicity’ [5,31]. This lesion is probably not simply 
explained by a defect in glucose transport or metabo- 
lism [22]. The reduction of PLA2 mRNA levels suggests 
that an impairment of PLA, activity might play a role 
in ‘glucose toxicity’; desensit&ation to glucose is nssoci- 
ated with an inhibition of the activity of another phos- 
pholipase (phospholipasc C) as well [13]. In addition to 
direct effects of glucose, elevated ambient insulin levels, 
accumulating in response to high glucose levels, could 
be involved mechanistically, since high insulin levels 
have been suggested to impede phospholipase activity 
[24] and any subsequent insulin release [25]. Insulin has 
also been reported to reduce type I1 PLA? expression in 
non-endocrine cells [26]. Future studies correlating 
Pl.Az protein levels, PLA, activity and insulin release 
will be required to address this novel hypothesis. Like- 
wise, elucidation of the site of nutrient action (c.g. on 
transcription or on the stability of mRNA) and of the 
molecular mechanisms involved will require additional 
investigations. 
,Ic~k,ro~r/r~f/~orrolrs: Thcsc sludics wcrc supporlcd by granls from ltlc 
Narional Instilulcs or Health (DK37312. DK.38325) and bs 1hC DC- 
pitrtmcnl oTVcterans AlTairs. The uxhnical assistance oTM:& Raba- 
gliu is gravzTully acknowlcdgcd. The nulhors are graierul IO Drs. 
Saka~a. Okarnolo and Arita ror supplying IIIC cDNA probes I‘or 
PLA:. 
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